University of East Anglia

Gaza update: political wrangling is making a peace deal even harder

Retrieved on: 
Giovedì, Giugno 13, 2024
East Anglia, Blight, National Unity, Benjamin Netanyahu, White, IDF, University, Good, University of East Anglia, Health, Ismail Haniyeh, News, The Wall Street Journal, Student, University College London, Ardfheis, Politics, Rage, Education, University of East London, History, Sinn Féin, Knesset, Weapon, Hostage, Rest

It’s not known how many people are buried beneath the rubble of the more than half of Gaza’s buildings that are reported to have been destroyed.

Key Points: 
  • It’s not known how many people are buried beneath the rubble of the more than half of Gaza’s buildings that are reported to have been destroyed.
  • Of those, 116 remain in Hamas hands, although one-third of these are now thought to have died.
  • Or, as he put it: “A deal that the entire world is behind, that Israel has accepted, and Hamas could have answered with a single word: ‘yes’.
  • The resignation doesn’t affect the numbers a great deal – Netanyahu still commands 64 of the 120 Knesset members.
  • * Read more: Gaza war: with both sides playing politics, don't expect a ceasefire any time soon * **

Two divided houses

  • One is in Gaza, led by military chief Yahya Sinwar, and one is in Doha, led by political chief Ismail Haniyeh.
  • Haniyeh, meanwhile, wants to plot a future for Gaza (with a role for Hamas) after the fighting stops.
  • At that stage, what complicated the issue was that Hamas did not recognise the existence of the state of Israel.
  • * Read more: Gaza war: a ceasefire depends on a leap of faith from both sides – Northern Ireland showed us how * **

A divisive issue

AV and EV Leader in Professional Turfgrass Mowing Technology, FireFly Automatix, Appoints Paul Richardson to Board of Directors

Retrieved on: 
Mercoledì, Gennaio 3, 2024
IOT (Internet of Things), General Sports, Golf, Construction & Property, Green Technology, Sustainability, Manufacturing, Technology, Robotics, Agritech, Environment, Sports, Other Technology, Machinery, Landscape, Engineering, Marketing, Grey Global Group, GSK plc, Multimedia, CFO, Audit committee, Information technology, VMLY&R, Young, Firefly, WPP, University of East Anglia, Season, Chartered accountant, Global 500, RealMedia, East Anglia, Social responsibility, Advertising, Growth, KPMG, Chime Communications Limited, WPP plc, Hanson (company), Beecham Group, EV, Management

Amid the continuing rollout of the fully autonomous AMP-L100 electric professional mower, FireFly Automatix , Inc. today announced the appointment of former WPP Group CFO, Paul Richardson, to its Board of Directors.

Key Points: 
  • Amid the continuing rollout of the fully autonomous AMP-L100 electric professional mower, FireFly Automatix , Inc. today announced the appointment of former WPP Group CFO, Paul Richardson, to its Board of Directors.
  • “Paul Richardson brings an extraordinarily deep skill set and acumen to FireFly from his decades of service in the operational strategy and finances of WPP,” said Andrew Limpert, CEO of FireFly Automatix.
  • Richardson trained as a Chartered Accountant in London with KPMG and is a Fellow of the Association of Corporate Treasurers.
  • Mike Pettingill, FireFly’s CFO, shared, “Paul Richardson brings a unique blend of detailed operational expertise, ‘Big Vision’ and humility to FireFly.

Horizon Europe: how the UK's delay in rejoining EU funding scheme is damaging scientific research

Retrieved on: 
Venerdì, Luglio 21, 2023
Association, Uncertainty, Food, International, East Anglia, University of East, Solution, University, Humanities, Research, Infection, University of East Anglia, Carbon, Government, Science, Pioneer, Climate change, Dislocation, Time, European, Framework Programmes for Research and Technological Development, Artificial intelligence, Brexit, Video game, Life insurance, Pharmaceutical industry, Nursing, Creative industries, Tourism, EU, Horizon

Run by the European Union (EU), it has a budget of €95.5 billion (£83 billion) spread over seven years – from 2021 to 2027.

Key Points: 
  • Run by the European Union (EU), it has a budget of €95.5 billion (£83 billion) spread over seven years – from 2021 to 2027.
  • There are ongoing negotiations between the EU and UK over associate membership, which has support from the scientific community.
  • For Horizon, EU issues calls for proposals, and teams of scientists from different institutions in several countries apply for the funding.

Damaging uncertainty

    • International partners are understandably cautious about inviting us into early discussions about collaborating on research projects.
    • They have similar concerns about future UK eligibility and about additional red tape.
    • This is a problem because large research consortia can often begin to form more than a year before a detailed proposal is finally submitted.
    • Consequently, we are already seeing fewer opportunities for UK-based researchers to collaborate with EU counterparts.

Disappearing advantage

    • Dislocation from Horizon Europe introduces undue layers of administrative bureaucracy and complexity not only for UK universities, but for our current and future collaborators elsewhere.
    • We would very much prefer to operate under the same regulatory environment for research as universities and research institutions in the rest of Europe.
    • The longer term effect of this is that we import fewer ideas and new approaches into the UK.

Plan B

    • This would be initiated in the event that UK association to Horizon Europe not be negotiated.
    • While there are some positive aspects to the £14.6 billion Pioneer programme, it does not match up to the opportunities offered by full UK association to Horizon Europe.
    • But the reality is that Horizon Europe is the largest and most successful research framework programme available to UK researchers.
    • This article was prepared with the help of Ian Beggs, European funding manager at the University of East Anglia.

Dalata Hotel Group PLC: Directorate change

Retrieved on: 
Venerdì, Luglio 14, 2023
United Kingdom, Chartered Institute of Management Accountants, ESG, Finance, East Anglia, WHSmith, University of East Anglia, Risk, Management, Travelodge

Dublin and London | 14 July 2023: Dalata Hotel Group plc ("Dalata" or the "Group" or the "Company"), the largest hotel operator in Ireland with a growing presence in the United Kingdom and continental Europe, announces the appointment of a new independent non-executive director.

Key Points: 
  • Dublin and London | 14 July 2023: Dalata Hotel Group plc ("Dalata" or the "Group" or the "Company"), the largest hotel operator in Ireland with a growing presence in the United Kingdom and continental Europe, announces the appointment of a new independent non-executive director.
  • The board is pleased to announce that Jon Mortimore will join the board as an independent non-executive director on 1 August 2023.
  • Jon is a graduate of the University of East Anglia and a member of the Chartered Institute of Management Accountants.
  • "I am delighted to welcome Jon to the Dalata board; he brings extensive executive experience across various consumer businesses in the UK and international markets, including in the hotel sector.

Wilson Sonsini Adds Meredith Krannich to Executive Advisory Program

Retrieved on: 
Martedì, Luglio 11, 2023
Legal, Science, Professional Services, Other Science, Molecular biology, Wilson Sonsini Goodrich & Rosati, IPO, EAP, University, East Anglia, Genetics, Private law, Culture, Biotechnology, Multimedia, University of East Anglia, Savills North America, Growth, Law

Wilson Sonsini Goodrich & Rosati, the premier provider of legal services to technology, life sciences, and growth enterprises worldwide, today announced that Meredith Krannich has joined the firm’s Executive Advisory Program.

Key Points: 
  • Wilson Sonsini Goodrich & Rosati, the premier provider of legal services to technology, life sciences, and growth enterprises worldwide, today announced that Meredith Krannich has joined the firm’s Executive Advisory Program.
  • Krannich joins Ken Siegel as a member of the firm’s innovative Executive Advisory Program, which offers clients experience-based, actionable, and business-focused advice.
  • Wilson Sonsini’s Executive Advisory Program supports clients at every stage, whether the client is a high-growth start-up, a late-stage company preparing for an IPO, or a multinational public company.
  • “We’re pleased to welcome her as the newest member of our Executive Advisory Program.

Immodulon Appoints New Chair and Leadership Team to Drive Late-Stage Clinical Development of IMM-101 in Pancreatic Cancer

Retrieved on: 
Mercoledì, Maggio 10, 2023
Pancreatic cancer, University, East Anglia, Molecular and Cellular Biology, Chemistry, Head, Peter, University of Warwick, MBA, University of East Anglia, Doctor of Philosophy, Bachelor of Science, Eli Lilly, University of Portsmouth, Acquisition, Cell biology, Patient, Tissue engineering, Master of Science, Corporation, ADC, Therapy, NYSE, Abraxis BioScience, Pfizer, Corporate development, Management, Fine chemical, Pharmaceutical industry, Amgen, Maastricht University, Economics, Celgene, Hospira

This new team brings decades of industry experience from leading global pharmaceutical companies including Celgene, Amgen, Hospira,   ADC Therapeutics and Alvotech.

Key Points: 
  • This new team brings decades of industry experience from leading global pharmaceutical companies including Celgene, Amgen, Hospira,   ADC Therapeutics and Alvotech.
  • Their expertise will be crucial in guiding IMM-101 through late-stage clinical development and maximising its potential for patients.
  • Immodulon has generated compelling Phase 2 data with IMM-101, which has the potential to make a real impact on the treatment of pancreatic cancer where patients have limited new treatment options.
  • I am excited to work with the team to accelerate the clinical development of IMM-101 in combination with Abraxane (nab-paclitaxel) and gemcitabine.

Prostate Cancer Treatment can be safely delayed, and inexpensively and accurately monitored thanks to new Artificial Intelligence

Retrieved on: 
Martedì, Marzo 28, 2023
Prostate, Prostate cancer, Urine, Medicine, Dres, The New England Journal of Medicine, Abnormality, CAD, Cancer, Research, University of East Anglia, Standard, NEJM, Metcalfe, Radiation therapy, MRI, University of Chicago Comprehensive Cancer Center, Rectum, Prostate cancer screening, Risk, Artificiality, Blood, Artificial intelligence, PSE, PCA, Diagnosis, Digital, AI, FDA, Standard of care, PSA, Men's Health, Medical imaging, Mobile phone

Therefore, biopsies are not an effective screening tool for prostate cancer, but are a confimatory tool if utilized with imaging guidance.

Key Points: 
  • Therefore, biopsies are not an effective screening tool for prostate cancer, but are a confimatory tool if utilized with imaging guidance.
  • In conclusion, bpMRI with CAD (AI) such as ProstatID, is poised to change the Standard of Care for Prostate Cancer screening, detection and diagnosis by avoiding the costly pitfalls of current prostate cancer pathways.
  • al., Fifteen-year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer, NEJM, March 11, 2023.
  • Circulating Chromosome Conformation Signatures Significantly Enhance PSA Positive Predicting Value and Overall Accuracy for Prostate Cancer Detection.

Extraordinary Leaders in Diabetes Research, Prevention, and Treatment to be Recognized at the ADA's 83rd Scientific Sessions

Retrieved on: 
Martedì, Marzo 14, 2023
Endoplasmic reticulum, Health information management, ADA, Calcium signaling, SBM, Research, Network, University of East Anglia, Hyperglycemia, Reward, National Health and Nutrition Examination Survey, Public, Disease, Cardiovascular disease, Mark Atkinson (scientist), Social media, Causality, University, Baylor College of Medicine, Foot, Kaiser Permanente, Lois Jovanovic, MPH, University of Missouri, Prediabetes, Doctor of Philosophy, Centers for Disease Control and Prevention, Risk, National Institutes of Health, Obesity, FACS, Knowledge, Patient, Insulin, Secretion, Bangladesh Technical Education Board, Female, Physician, Stomach, Pregnancy, Mark, National Health, RDN, Baylor University, Atherosclerosis, Pharmaceutical industry, Dentistry, Ageing, Medicine, Health, MD, MBBS, Diabetes, Golgi, Epidemiology

ARLINGTON, Va., March 14, 2023 /PRNewswire/ -- The American Diabetes Association® (ADA) is thrilled to announce the recipients of the 2023 National Scientific and Health Care Achievement Awards. The awards honor academics, health care providers, and educators who have contributed to substantial advances in the field of diabetes care and research. With the help of these leaders and their steadfast dedication, we move closer to achieving the mission of the ADA: To prevent and cure diabetes and to improve the lives of all people affected by diabetes.

Key Points: 
  • Dr. Tschöp's subsequent discovery of novel classes of dual and triple gut hormone drugs already transformed the fight against obesity and diabetes.
  • Carmella Evans-Molina, MD, PhD is the recipient of the 2023 Outstanding Scientific Achievement Award, which recognizes research in diabetes that demonstrates particular independence of thought and originality.
  • He has published over 180 scientific papers in prestigious journals and is an international thought leader in the field of diabetes.
  • The ADA's 83rd Scientific Sessions, the world's largest scientific meeting focused on diabetes research, prevention, and care, will be held in San Diego, CA on June 23–26.

Oxford BioDynamics’ Prostate Screening EpiSwitch® Blood Test Significantly Enhances Overall Detection Accuracy For At Risk Men

Retrieved on: 
Lunedì, Febbraio 6, 2023
Oncology, Health, Medical Devices, Consumer, Men, Pharmaceutical, Biotechnology, Prostate, Prostate-specific antigen, Imperial College Healthcare NHS Trust, Prostate cancer, Microenvironment, The New England Journal of Medicine, Blood, PSA, AIM, Norwich Medical School, Diagnosis, MRI, LDT, Patient, Trust, Imperial College London, University of East Anglia, Chromatin, Risk, Translational medicine, NHS, Survival, Journal of Translational Medicine, Cirth, MedRxiv, Genomics, PSE, ICIS, Checkpoint, OBD, Charing Cross Hospital, 3D, Global health, Pharmaceutical industry, Medical imaging, Surgeon, Medicine, Cancer

A positive result from a standard PSA test is unreliable and often suggests prostate cancer is present when no cancer exists.

Key Points: 
  • A positive result from a standard PSA test is unreliable and often suggests prostate cancer is present when no cancer exists.
  • The inaccuracy of current screening protocols leads to many men getting unnecessary referrals for expensive MRI scans and highly invasive, medieval biopsies.
  • The resultant Prostate Screening EpiSwitch® (PSE) blood test, which combines the PSA component and the EpiSwitch classifier, demonstrated a remarkable 92%:94% positive:negative predictive value and an accuracy of 94%.
  • Circulating Chromosome Conformation Signatures Significantly Enhance PSA Positive Predicting Value and Overall Accuracy for Prostate Cancer Detection.

Disrupting the Disruptors: Proptech Platform Homemove Secures $400,000 in Funding

Retrieved on: 
Martedì, Gennaio 17, 2023
Aston, Watsons, University of East Anglia, Jaguar Land Rover, Trust, Eilidh, Estate agent, East Anglia, Partnership, National Association, Growth, Aston University, Fuel, Bachelor, Legal & General, Friction, Research, Sale, CRMS, Commercial, Real estate, Management, NORWICH

NORWICH, England, Jan. 17, 2023 /PRNewswire/ -- Homemove , a tech platform connecting sellers, buyers and renters with vetted, trusted and established home moving services, has raised $400,000 in pre-seed funding to aid rapid growth.

Key Points: 
  • NORWICH, England, Jan. 17, 2023 /PRNewswire/ -- Homemove , a tech platform connecting sellers, buyers and renters with vetted, trusted and established home moving services, has raised $400,000 in pre-seed funding to aid rapid growth.
  • In an effort to challenge the so-called 'disruptors', Homemove will be promoting the best local and independent service providers who prioritise their clients' best interests.
  • Louis O'Connell-Bristow , Homemove co-founder & CEO, said: "My vision is to significantly improve the home moving process and this funding round is a major step towards achieving that goal.
  • James Freestone , Homemove co-founder & COO, said: "At Homemove, we are not just building a brand, we are building a legacy of trust and excellence.